Definitive Contract 75A50123C00070
Award Date
9/30/23
Potential Completion Date
8/31/25
Potential Value
$409K
Awardee
Univercells
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Belgium
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, with a ceiling value of $86,670,401.90, is for biomedical (advanced) products and services. The prime contractor is Janssen Vaccines & Prevention B.V., a foreign-owned for-profit organization. The contract does not have a set-aside designation and has an ultimate completion date...
The U.S. Department of Health and Human Services Food and Drug Administration (HHS/FDA) awarded a Firm Fixed Price purchase order to Univercells Technologies, a foreign-owned for-profit organization, for the purchase of a Scale-X Carbo Cell Culture Bioreactor System and consumables. The contract, which has a Coronavirus COVID-19 National Interest Action Code, is valued at $245,730.00 and has a completion date of February 15, 2021. The contract was awarded on September 18, 2020 and was not set...
This is a $65,806,649.98 cost-plus-fixed-fee definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Biofactura Inc., a for-profit manufacturer located in Frederick, Maryland. The contract includes preclinical and manufacturing development activities such as cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract has an...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $627,627.92 definitive contract to Nature's Toolbox Inc., doing business as Biotechnology, a subsidiary of Nature's Toolbox, Inc., for research and development of a novel, rapidly deployable RNA vaccine production platform under AOI #21 Vaccines on Demand. The firm fixed price contract will be performed in Mexico over a period of approximately two years, from April 2023 through...
This is a $594,566 firm-fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Flag Bio, Inc. for the development of an mRNA vaccine. The contract has an ultimate completion date of August 31, 2026 and was awarded on September 1, 2024. The original contract opportunity was a pre-solicitation for the NIH and CDC Small Business Innovation Research (SBIR) program, which aims to stimulate technological innovation and strengthen the...
This is a $1,754,345,480.45 definitive cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Moderna, Inc. for the development of an mRNA vaccine to licensure for the prevention of COVID-19. The contract includes pre-award costs, development of the mRNA vaccine to Biologics License Application (BLA), and domestic manufacturing scale-out. This award does not have a set-aside designation. Moderna, a for-profit pharmaceutical...
This is a $93,164,303.39 cost plus fixed fee definitive contract awarded by the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization, on September 14, 2015. The contract has an ultimate completion date of August 16, 2024 and is not set-aside. The contract is for products and services related to HHS's preparedness and response programs, though...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Promega Corporation for a custom large scale RNA transcription system. The $128,200 contract calls for Promega to deliver eight units of its AX7650X system over four shipments between July 2022 and May 2023 to support the NIH Vaccine Research Center's mRNA vaccine development efforts. The solicitation indicated the...
<p>This is a cost-plus-fixed-fee definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Janssen Vaccines & Prevention B.V. (JPC), a foreign-owned for-profit organization. The $196,408,488.00 contract does not have a set-aside designation and has an ultimate completion date of March 30, 2026. The contract was awarded on September 28, 2017.</p>
This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for the development of an integrated cGMP facility for mRNA manufacturing. The contract is valued at $82,182,000.00 and has a completion date of September 28, 2026. It is a Firm Fixed Price contract with no set-aside designation. MIT has subcontracted with The Pennsylvania State University and Rensselaer Polytechnic Institute to perform research related to mRNA...